JORIEUX; Sylvie
Patent Applications and Registrations
Patent applications and USPTO patent grants for JORIEUX; Sylvie.The latest application filed is for "factor h fragment for use as an anti-angiogenic agent".
- JORIEUX; Sylvie - Lomme FR
- Jorieux; Sylvie - Villeneuve D'Ascq FR
| Patent | Date |
|---|---|
| Factor H Fragment For Use As An Anti-angiogenic Agent App 20190388506 - DINET; Virginie ; et al. | 2019-12-26 |
| Use of ADCC-optimized antibodies for treating low-responder patients Grant 9,879,089 - Bourel , et al. January 30, 2 | 2018-01-30 |
| Optimized FC variants Grant RE46,585 - Behrens , et al. October 24, 2 | 2017-10-24 |
| Optimized FC variants Grant RE45,992 - Behrens , et al. May 3, 2 | 2016-05-03 |
| Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20150307624 - Bourel; Dominique ; et al. | 2015-10-29 |
| Use of ADCC-optimized antibodies for treating weak patients Grant 9,109,020 - Bourel , et al. August 18, 2 | 2015-08-18 |
| Fc Variants With Reduced Effector Functions App 20140378663 - Fontayne; Alexandre ; et al. | 2014-12-25 |
| Optimized FC variants Grant 8,742,074 - Behrens , et al. June 3, 2 | 2014-06-03 |
| Use Of Adcc-optimized Antibodies For Treating Weak Patients App 20140017243 - Bourel; Dominique ; et al. | 2014-01-16 |
| Use of ADCC-optimized antibodies for treating weak patients Grant 8,501,171 - Bourel , et al. August 6, 2 | 2013-08-06 |
| Anti-rhesus D monoclonal antibody Grant 8,404,241 - Gaucher , et al. March 26, 2 | 2013-03-26 |
| Optimized Fc Variants App 20120009188 - Behrens; Christian ; et al. | 2012-01-12 |
| Anti-rhesus D Monoclonal Antibody App 20110311556 - Gaucher; Christine ; et al. | 2011-12-22 |
| Use of ADCC-Optimized antibodies for treating weak patients App 20100303826 - Bourel; Dominique ; et al. | 2010-12-02 |
| Use of ADCC-optimized antibodies for treating low-responder patients Grant 7,713,524 - Bourel , et al. May 11, 2 | 2010-05-11 |
| Treatment Of Pathologies Which Escape The Immune Response, Using Optimized Antibodies App 20090081216 - de ROMEUF; Christophe ; et al. | 2009-03-26 |
| Method For Preparing Antibodies Selective For Activating Fc Receptors App 20090029393 - Teillaud; Jean-Luc ; et al. | 2009-01-29 |
| Novel lgG3 Antibodies for Stimulating Phagocytosis App 20070218052 - Romeuf; Christophe De ; et al. | 2007-09-20 |
| Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity App 20070015239 - Bihoreau; Nicolas ; et al. | 2007-01-18 |
| Use of adcc-optimized antibodies for treating weak patients App 20060182741 - Bourel; Dominique ; et al. | 2006-08-17 |
| Treatment of pathologies which escape the immune response, using optimised antibodies App 20050271652 - de Romeuf, Christophe ; et al. | 2005-12-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 